Skip to main content

Questions about COVID-19 and your benefits?  Learn more here

How data can support drug benefits


Share this post

In this Avantages article, Marie-Hélène Dugal, Product Portfolio Manager, Drug Management Solutions, Medavie Blue Cross, explains how data analysis makes it possible to leverage technology to improve members’ health.

According to Marie-Hélène "with data, we can reimburse the right medication, to the right patient, at the right time and the right price" by using an algorithm to confirm patient adherence to treatment and if current dosage is appropriate.

Moreover, the trends emerging from this data can help determine which medication generates the most expenses and target actions accordingly.

Read the article to learn more about the opportunities offered by data analysis (article in French only).

Marie-Hélène Dugal

Marie-Hélène Dugal has been with Medavie Blue Cross for 15 years. Over the course of her career, she has...